▶ 調査レポート

D-ビオチンのグローバル市場(~2027):1%ビオチン、2%ビオチン、純ビオチン(>98%)

• 英文タイトル:D-Biotin Market Research Report by Product, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

D-Biotin Market Research Report by Product, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19「D-ビオチンのグローバル市場(~2027):1%ビオチン、2%ビオチン、純ビオチン(>98%)」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2304E065
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、225ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社発行の当市場調査レポートでは、2021年に312.67百万ドルであった世界のD-ビオチン市場規模が、2022年に346.85百万ドルに達し、2027年には588.23百万ドルまでCAGR 11.10%で成長すると見込まれています。当レポートは、D-ビオチンの世界市場を多角的に調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別(1%ビオチン、2%ビオチン、純ビオチン(>98%))分析、用途別(動物飼料、食品産業、製薬&化粧品)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況など、以下の項目をまとめています。また、当書は、Adina Chemicals Ltd.、Central Drug House Pvt. Ltd、Charkit Chemical Company、Creative Enzymes、Dastech International Inc.、DSM Corporation、ETChem、Fengchen Group Co., Ltd、Foodchem International Corporationなどの企業情報を含んでいます。

・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界のD-ビオチン市場規模:製品別
- 1%ビオチンの市場規模
- 2%ビオチンの市場規模
- 純ビオチン(>98%)の市場規模
・世界のD-ビオチン市場規模:用途別
- 動物飼料における市場規模
- 食品産業における市場規模
- 製薬&化粧品における市場規模
・世界のD-ビオチン市場規模:地域別
- 南北アメリカのD-ビオチン市場規模
アメリカのD-ビオチン市場規模
カナダのD-ビオチン市場規模
ブラジルのD-ビオチン市場規模

- アジア太平洋のD-ビオチン市場規模
日本のD-ビオチン市場規模
中国のD-ビオチン市場規模
インドのD-ビオチン市場規模
韓国のD-ビオチン市場規模
台湾のD-ビオチン市場規模

- ヨーロッパ/中東/アフリカのD-ビオチン市場規模
イギリスのD-ビオチン市場規模
ドイツのD-ビオチン市場規模
フランスのD-ビオチン市場規模
ロシアのD-ビオチン市場規模

- その他地域のD-ビオチン市場規模

・競争状況
・企業情報

The Global D-Biotin Market size was estimated at USD 312.67 million in 2021 and expected to reach USD 346.85 million in 2022, and is projected to grow at a CAGR 11.10% to reach USD 588.23 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the D-Biotin to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across 1% Biotin, 2% Biotin, and Pure Biotin (>98%).

Based on Application, the market was studied across Animal Feed, Food Industry, and Pharma & Cosmetics.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for D-Biotin market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the D-Biotin Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global D-Biotin Market, including Adina Chemicals Ltd., Central Drug House Pvt. Ltd, Charkit Chemical Company, Creative Enzymes, Dastech International Inc., DSM Corporation, ETChem, Fengchen Group Co.,Ltd, Foodchem International Corporation, Green Wave Ingredients Inc.., Hangzhou Kexing Biochem Co.,Ltd., Lonwin Industry Group Limited., Newseed Chemical Co., Limited, Parchem fine & specialty chemicals., Salvavidas Pharmaceutical Pvt. Ltd., Samex Overseas, Sigma-Aldrich, Inc., VWR International, LLC., Wellona Pharma Private Limited, and Zhejiang Shengda Bio-pharm Co.,Ltd..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global D-Biotin Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global D-Biotin Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global D-Biotin Market?
4. What is the competitive strategic window for opportunities in the Global D-Biotin Market?
5. What are the technology trends and regulatory frameworks in the Global D-Biotin Market?
6. What is the market share of the leading vendors in the Global D-Biotin Market?
7. What modes and strategic moves are considered suitable for entering the Global D-Biotin Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing use of D-Biotin in cosmetic products
5.1.1.2. Rising prevalence of biotin deficiency issues such as malnutrition, hair & weight loss, and associated with pregnancy
5.1.2. Restraints
5.1.2.1. The product may have negative effect on some medications and medical conditions
5.1.3. Opportunities
5.1.3.1. Rising focus and spending over the pet’s health
5.1.3.2. Expanding pharma and cosmetic industries in developing economies
5.1.4. Challenges
5.1.4.1. Lack of awareness regarding the importance of right nutrition and high levels of biotin in patients’ blood can cause incorrect lab results
5.2. Cumulative Impact of COVID-19

6. D-Biotin Market, by Product
6.1. Introduction
6.2. 1% Biotin
6.3. 2% Biotin
6.4. Pure Biotin (>98%)

7. D-Biotin Market, by Application
7.1. Introduction
7.2. Animal Feed
7.3. Food Industry
7.4. Pharma & Cosmetics

8. Americas D-Biotin Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific D-Biotin Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa D-Biotin Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Adina Chemicals Ltd.
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Central Drug House Pvt. Ltd
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Charkit Chemical Company
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Creative Enzymes
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Dastech International Inc.
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. DSM Corporation
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. ETChem
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Fengchen Group Co.,Ltd
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Foodchem International Corporation
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Green Wave Ingredients Inc..
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Hangzhou Kexing Biochem Co.,Ltd.
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Lonwin Industry Group Limited.
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Newseed Chemical Co., Limited
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Parchem fine & specialty chemicals.
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Salvavidas Pharmaceutical Pvt. Ltd.
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. Samex Overseas
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. Sigma-Aldrich, Inc.
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. VWR International, LLC.
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Wellona Pharma Private Limited
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. Zhejiang Shengda Bio-pharm Co.,Ltd.
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing